Welcome to Benzinga’s psychedelic headlines roundup for the first two weeks of March 2024. In this edition, we highlight must-read news items that cover a wide range of topics, from research on the therapeutic effects of psilocybin to updates on the psychedelic industry and upcoming events in the field.
Research in the field of psychedelics continues to expand, with several studies shedding light on the potential benefits of psychedelic-assisted therapy for mental health conditions such as major depressive disorder. A study on the therapeutic alliance between study participants and intervention facilitators found that it is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. Another study explored the effect of psilocybin on empathy and prosocial behavior, proposing a mechanism for enduring antidepressant effects.
In addition to research studies, there are also articles discussing the ethical considerations of psychedelic therapy, the regulatory landscape surrounding psychedelics, and the cultural impact of psychedelics on society. From bioethics to psychedelic lobbying and regulatory capture, these articles provide valuable insights into the evolving landscape of psychedelic research and therapy.
The roundup also includes news from the psychedelic industry, with updates on companies such as Clearmind Medicine, atai Life Sciences, and BetterLife. These companies are making strides in developing new treatments for mental health conditions using psychedelic compounds, and their progress is closely watched by investors and industry stakeholders.
Lastly, the roundup features a list of upcoming events in the psychedelic community, including webinars, conferences, and training programs. From the UC Berkeley Center for the Science of Psychedelics to the Harvard Law School Center’s Psychedelics Bootcamp, there are plenty of opportunities for professionals and enthusiasts to engage with the latest developments in psychedelic research and therapy.
Overall, the first two weeks of March 2024 have been filled with exciting news and developments in the world of psychedelics. Whether you are a researcher, investor, or simply curious about the potential of psychedelic therapy, there is no shortage of interesting and informative content to explore in this roundup. Stay tuned for more updates and headlines from Benzinga as the psychedelic industry continues to evolve and grow.
